Australia markets closed

Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
3.5000+0.1100 (+3.24%)
At close: 03:04PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,119,861
1,197,562
1,615,323
2,361,946
1,214,504
Cost of revenue
930,509
1,001,556
1,268,545
1,826,113
950,996
Gross profit
189,352
196,007
346,778
535,833
263,508
Operating expenses
Research development
6,628
7,661
25,759
39,364
43,155
Selling general and administrative
76,554
78,212
94,617
111,766
89,854
Total operating expenses
113,060
115,753
161,531
230,772
170,559
Operating income or loss
76,293
80,254
185,247
305,061
92,949
Interest expense
64,625
61,315
56,031
37,949
15,561
Income before tax
-730,205
-681,010
71,826
158,324
58,414
Income tax expense
-
26,324
27,254
-1,007
-7,877
Income from continuing operations
-757,642
-707,335
44,572
159,330
66,292
Net income
-630,201
-605,653
-23,273
49,105
25,320
Net income available to common shareholders
-630,201
-605,653
-23,273
49,105
25,320
Basic EPS
-0.48
-1.73
-0.07
0.14
0.07
Diluted EPS
-0.48
-1.73
-0.07
0.14
0.07
Basic average shares
350,553
350,332
350,502
350,246
350,207
Diluted average shares
350,553
350,332
350,502
350,246
350,207